Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,921.50    18.00 (0.95%)
Bid:
1,920.00
Ask:
1,920.50
Spread: 0.50 (0.026%)
Market Cap: £77.03b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

US advisers to consider RSV shots as GSK looks to keep market lead
26 Jun 2024

US advisers to consider RSV shots as GSK looks to keep market lead

June 26 (Reuters) - A committee of outside experts to the U.S. CDC are set to vote on whether to expand the age group of adults who should receive r...

Merck KGaA shares plunge after cancer drug hopeful fails
25 Jun 2024

Merck KGaA shares plunge after cancer drug hopeful fails

FRANKFURT, June 25 (Reuters) - Shares in Germany's Merck KGaA slumped 8.9% at the open on Tuesday after the diversified group late on Monday said a ...

TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU
24 Jun 2024

TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU

(Alliance News) - GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU.

LONDON BRIEFING: Prudential announces buyback; Frasers and THG in deal
24 Jun 2024

LONDON BRIEFING: Prudential announces buyback; Frasers and THG in deal

(Alliance News) - London's FTSE 100 is called to open lower at the start of the week, with share price falls for major US tech shares, Nvidia included...

GSK reports regulatory progress for Omjjara, Jemperli
24 Jun 2024

GSK reports regulatory progress for Omjjara, Jemperli

(Sharecast News) - GSK announced on Monday that it has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for 'Omjjara', or ...

Industry groups back drugmakers' appeal in Zantac cancer lawsuits
20 Jun 2024

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has rece...

Zantac litigation fears overdone at GSK, says Shore Capital
11 Jun 2024

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but th...

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware
11 Jun 2024

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its disc...